BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 27829864)

  • 1. Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells.
    Gao S; Pan Y; Song L; Dong L; Weng LI; Wang P; Hua Y; Chen Z; Liu L
    Evid Based Complement Alternat Med; 2016; 2016():7028289. PubMed ID: 27829864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals.
    Chen P; Wang M; Wang C
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31147453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1.
    Xu Y; Xu S; Cai Y; Liu L
    Evid Based Complement Alternat Med; 2015; 2015():145016. PubMed ID: 26783407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ski acts as therapeutic target of qingyihuaji formula in the treatment of SW1990 pancreatic cancer.
    Wang P; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Liu LM
    Integr Cancer Ther; 2010 Mar; 9(1):50-8. PubMed ID: 20308085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway.
    Hua YQ; Chen Z; Meng ZQ; Chen H; Shen JG; Wang K; Peng W; Shen YH; Liu LM
    Oncol Lett; 2014 Jul; 8(1):17-24. PubMed ID: 24959213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF.
    Yin JH; Shi WD; Zhu XY; Chen Z; Liu LM
    Integr Cancer Ther; 2012 Mar; 11(1):37-47. PubMed ID: 21382954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor effect of the extract from qingyihuaji formula on pancreatic cancer by down-regulating Notch-4 and Jagged-1.
    Xu Y; Zhu F; Xu S; Liu L
    J Tradit Chin Med; 2015 Feb; 35(1):77-83. PubMed ID: 25842732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of baicalein on pancreatic cancer stem cells via modulation of sonic Hedgehog pathway.
    Song L; Chen X; Wang P; Gao S; Qu C; Liu L
    Acta Biochim Biophys Sin (Shanghai); 2018 Jun; 50(6):586-596. PubMed ID: 29697746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Babaodan Capsule () combined with Qingyi Huaji Formula () in advanced pancreatic cancer-a feasibility study.
    Song LB; Gao S; Zhang AQ; Qian X; Liu LM
    Chin J Integr Med; 2017 Dec; 23(12):937-942. PubMed ID: 28664246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ROR functions as a ceRNA to regulate Nanog expression by sponging miR-145 and predicts poor prognosis in pancreatic cancer.
    Gao S; Wang P; Hua Y; Xi H; Meng Z; Liu T; Chen Z; Liu L
    Oncotarget; 2016 Jan; 7(2):1608-18. PubMed ID: 26636540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Qingyi Huaji decoction on serum levels of interleukin-6, interleukin-8 and tumor necrosis factor-alpha in nude mice bearing pancreatic tumors.
    Ouyang HQ; Liu LM; Chen Z; Luo JM; Yu EX
    Zhong Xi Yi Jie He Xue Bao; 2010 Jul; 8(7):655-61. PubMed ID: 20619142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of NANOG in cancer cells.
    Gong S; Li Q; Jeter CR; Fan Q; Tang DG; Liu B
    Mol Carcinog; 2015 Sep; 54(9):679-87. PubMed ID: 26013997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of Qingyi Huaji formula for inhibition of pancreatic cancer cell growth through down-regulating Ski expression].
    Wang P; Liu LM; Chen Z
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Sep; 30(9):942-5. PubMed ID: 21179734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of differential β-catenin expression with Oct-4 and Nanog in oral squamous cell carcinoma and their correlation with clinicopathological factors and prognosis.
    Ravindran G; Sawant SS; Hague A; Kingsley K; Devaraj H
    Head Neck; 2015 Jul; 37(7):982-93. PubMed ID: 24700702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas.
    Rasti A; Mehrazma M; Madjd Z; Abolhasani M; Saeednejad Zanjani L; Asgari M
    Sci Rep; 2018 Aug; 8(1):11739. PubMed ID: 30082842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sanguinarine inhibits pancreatic cancer stem cell characteristics by inducing oxidative stress and suppressing sonic hedgehog-Gli-Nanog pathway.
    Ma Y; Yu W; Shrivastava A; Alemi F; Lankachandra K; Srivastava RK; Shankar S
    Carcinogenesis; 2017 Oct; 38(10):1047-1056. PubMed ID: 28968696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oct4 and Nanog expression is associated with early stages of pancreatic carcinogenesis.
    Wen J; Park JY; Park KH; Chung HW; Bang S; Park SW; Song SY
    Pancreas; 2010 Jul; 39(5):622-6. PubMed ID: 20173672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Notch2(+) pancreatic cancer stem-like cells and the relationship with centroacinar cells.
    Zhou ZC; Dong QG; Fu DL; Gong YY; Ni QX
    Cell Biol Int; 2013 Aug; 37(8):805-11. PubMed ID: 23536545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
    Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell transcription factor NANOG in cancers--is eternal youth a curse?
    Wong OG; Cheung AN
    Expert Opin Ther Targets; 2016; 20(4):407-17. PubMed ID: 26634876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.